Recombinant Mutant Human Tumor Necrosis Factor for Injection重组改构人肿瘤坏死因子

发送询盘加到询盘篮

详细描述

产品描述：

Recombinant Mutant Human Tumor Necrosis Factor for Injection

[Dosage form] Freeze-dried powder for injection.

[Indication]

in the treatment of non-small cell lung cancer (NSCLC）	Combined therapy with NP chemotherapy (NVB+DDP）
	Combined therapy with MVP chemotherapy vindesine+DDP+MMC）
	or in ineffective therapy for advanced or recurrent NSCLC patients with other methods
in the treatment of non-Hodgkin's lymphoma（NHL）	Combined therapy with BACOP chemotherapy
	(Cyclophosphamide +Vincristine +Doxorubicin ADM+Bleomycin +Prednisone )
	or be used in trial by chemotherapy or other methods in the treatment of advanced NHL of invalid patients

[Highlight]

•Promoting the concentration of chemotherapeutic drugs in tumor by 4 to 6 times

•Owning synergistic effect by combining various chemotherapeutics

•Promoting chemotherapeutic effect of advanced NSCLC and NHL significantly

•Effective rate is 87% in the treatment of Malignant pleural effusion applied as single drug

•Effective rate is 66.67% in the treatment of NHL applied as single drug

•The first recombinant mutant human tumor necrosis factor in the globe

深圳市迈高生物科技有限公司 8

联系信息公司快照

● 地址：

● 城市：

● 联系人：

● 电话：

● 传真：

访问供应商商铺

成为供应商在线获取商机

快速询盘